The document discusses the anatomy, physiology, and disorders of the Eustachian tube. It describes the Eustachian tube's embryological development and details its adult anatomy including measurements, parts, musculature, and blood supply. Regarding function, it ventilates the middle ear and drains secretions. Dysfunctions include tubal blockage from various mechanical or functional causes like adenoids, cleft palate, or barotrauma. Tests to evaluate Eustachian tube function include Valsalva, Toynbee, and tympanometry. Disorders include tubal blockage, retraction pockets, and a patulous tube.
I have tried my level best to complete this one. Basics & subjective details as much possible, are included here with understandable diagrams, CT-scans & charts. Clinical associations with possible anatomical structures are also touched . Frequent questions based on the topic discussed, will be there at the middle & end of presentation.
If you find it helpful then please like it & if any query regarding this ppt or upcoming ppts then mail me
drsuraj1997@gmail.com
Development of the middle ear is not covered in this presentation. If you are interested then please mail me. I will try to upload it as a separate one.
I have tried my level best to complete this one. Basics & subjective details as much possible, are included here with understandable diagrams, CT-scans & charts. Clinical associations with possible anatomical structures are also touched . Frequent questions based on the topic discussed, will be there at the middle & end of presentation.
If you find it helpful then please like it & if any query regarding this ppt or upcoming ppts then mail me
drsuraj1997@gmail.com
Development of the middle ear is not covered in this presentation. If you are interested then please mail me. I will try to upload it as a separate one.
External ear,tympanic membrane and auditory tube Dr.N.Mugunthan.M.S.,mgmcri1234
External ear,tympanic membrane and auditory tube - Lecture by Dr.N.Mugunthan.M.S.,Associate Professor, Mahatma Gandhi Medical College & Research Institute, Pondicherry,
Sri Balaji Vidyapeeth University.
Spaces of middle ear and their surgical importanceDr Soumya Singh
one of the imp topics in ENT that should be understood very thoroughly if u want to pursue as an otologist.I tried to simplify the topic with simple diagrams and models for better understanding .
External ear,tympanic membrane and auditory tube Dr.N.Mugunthan.M.S.,mgmcri1234
External ear,tympanic membrane and auditory tube - Lecture by Dr.N.Mugunthan.M.S.,Associate Professor, Mahatma Gandhi Medical College & Research Institute, Pondicherry,
Sri Balaji Vidyapeeth University.
Spaces of middle ear and their surgical importanceDr Soumya Singh
one of the imp topics in ENT that should be understood very thoroughly if u want to pursue as an otologist.I tried to simplify the topic with simple diagrams and models for better understanding .
Links the pharynx to the middle ear
Eustachius (1562) termed it as Pharyngotympanic tube and Antonio Valsalva as the Eustachian tube. It
Develops from tubotympanic recess which is derived from endoderm of 1st pharyngeal pouch It is
36 mm long in adults .It is
Directed anteriorly, inferiorly and medially from anterior wall of middle ear forming an angle of 45degrees with horizontal and sagittal planes
It enters the lateral wall of nasopharynx 1.25 cm behind posterior end of inferior turbinate.
Lateral 1/3 - bony
Medial 2/3 - fibro-cartilaginous
Junction between 2 parts -- isthmus, narrowest part of Eustachian tube
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE
Eustachian tube, anatomy, test and disorders, dr.vijaya sundarm, 20.03.17
1. Anatomy , test and disorders
of Eustachian Tube
BY
DR.VIJAYASUNDARAM
ASSOCIATE PROFESSOR1
2. History
• Bartolomeus Eustachius first described it
as pharyngo-tympanic tube in 1562.
• Antonio Valsalva named it Eustachian
tube.
2
3. Embryology
• Develops from tubo-tympanic recess, derived from
endoderm of 1st pharyngeal pouch.
• the distal portion of the pouch expands and forms
middle ear cavity
• Proximal portion forms the Eustachian tube
• cartilage and muscles develop from surrounding
mesoderm
3
6. Anatomy
• 36 mm long in adults.
• Directed anteriorly, inferiorly & medially from anterior wall of
M.E., forming angle of 450 with horizontal
• Enters naso-pharynx 1.25 cm behind posterior end of inferior
turbinate.
• Channel connecting tympanic cavity and nasopharynx
• lumen of the Eustachian tube is roughly triangular, measuring
2-3 mm vertically and 3-4 mm horizontally.
6
9. Parts
• Lateral 1/3 is bony
• Medial 2/3 is fibro-
cartilaginous.
• Junction b/w 2 parts is
isthmus, narrowest part
of Eustachian Tube.
9
10. Anatomy of medial 2/3rd
Cartilage plate lies postero-
medially & consists of medial
+ lateral laminae separated
by elastin hinge. Fibrous
tissue + Ostmann’s fat pad lie
antero-laterally.
10
11. • Bony part :
• 12mm long
• widest at tympanic end
• gradually narrows towards isthmus (2mm)
• Thin plate of separating from tensor
tympani superiorly
• Plate of bone separating from internal
carotid medially
11
12. • Cartilaginous part
• 24mm long
• Cartilage forms posteromedial wall and a small
portion anterolaterally
• sits in a groove between petrous temporal bone
and greater wing of sphenoid
• nasopharyngeal opening surrounded by tubal
elevation above and behind
• Fossa of Rosen Muller lying behind this tubal
elevation
12
14. Anatomy
Muscle attachments:
Muscles attached to ET
Levaor palati – lower surface of petrous bone and cartilage and
fascia of upper carotid sheath
Tensor palati- bony wall of scaphoid and whole length of short
cartilaginous flange
Salphingo pharyngeus – inferior part of cartilage near its
pharyngeal end
Tensor tympani – cartilage of ET, surrounding bony canal and
greater wing of sphenoid
14
15. Nerve supply
• Tubal mucosa – tympanic branch of cranial
nerve IX
• Tensor veli palatini - Mandibular branch of
trigeminal
15
• Levator veli palatini
Pharyngeal plexus
• Salpingo pharygeus
16. Endoscopic Anatomy
• Medial end forms tubal
elevation / torus tubarius
• Lymphoid collection over
torus is called Gerlach’s tubal
tonsil.
• Postero-superior to torus is
fossa of Rosenmüller.
16
18. Adult vs INFANT
ADULT INFANT
Length 36 mm 18 mm
Angle with horizontal 45 0 10 0
Lumen Narrower Wider
Angulation at isthmus Present Absent
Cartilage Rigid Flaccid
Elastic recoil Effective Ineffective
Ostmann’s fat More Less
18
19. Infant E. tube
• wider shorter and more horizontal
So secretions even milk can regurgitate from
nasopharynx to middle ear if infant not fed in head
up position
19
20. Physiology
• Bony part is always open.
• Fibro-cartilaginous part is closed at rest.
• Opens on:
1. swallowing
2. yawning
3. sneezing
4. forceful inflation
20
21. Physiology
• Opens actively by contraction of tensor veli palatini &
passively by contraction of levator veli palatini (it
releases the tension on tubal cartilage).
• Closes by elastic recoil of elastin hinge + deforming
force of Ostmann’s fat pad.
21
23. Functions
1. Ventilation & maintenance of atmospheric
pressure in middle ear for normal hearing
2. Drainage of middle ear secretions into
nasopharynx by muco-ciliary clearance,
pumping action of Eustachian tube &
presence of intra-luminal surface tension
23
24. Functions
3. Protection of middle ear from:
– Ascending nasopharyngeal secretions due to
narrow isthmus & angulation between 2 parts of
E.T. at isthmus
– Pressure fluctuations
– Loud sound coming through pharynx
24
30. ET Function Tests
• VALSALVA TEST
– Principle: positive pressure in the nasopharynx causes air
to enter the Eustachian tube
30
31. – Tympanic membrane perforation- a hissing sound
– Discharge in the middle ear- cracking sound
– Only 65% of persons can do this test.
– Contraindications:
• Atrophic scar of tympanic membrane which can rupture
• Infection of nose & nasopharynx
31
32. • Politzer test
– Done in children who are unable to perform valsalva
test.
– Olive shaped tip of the politzer’s bag is introduced
into the patient’s nostril on the side of which the tubal
function is desired to be tested
– Other nostril closed & the bag compressed while at
the same time the patient swallows or says “ik,ik,ik”
32
33. – By means of an auscultation tube a hissing sound
is heard.
– Compressed air can also be used instead of
politzer’s bag
– Test is also therapeutically used to ventilate the
middle ear.
33
35. • Procedure for Catheterisation
35
•Nose is anaesthetised
•E Tube catheter passed along the floor of nose till it
reaches naso pharynx
•Rotated 90deg medially
•Pulled back till posterior border of nasal septum
engaged
•Rotated 180 deg laterally – tip lies against tubular
opening
• Politzer’s bag connected
• Air insufflated
• Entry of air to middle ear verified (lateral bulging of
t.m)
36. 6. E.T. catheterization
Air pushed into E.T. catheter by squeezing Politzer bag.
Examiner hears by Toynbee auscultation tube put in
pt's ear.
Blowing sound = normal E.T. patency
Bubbling sound = middle ear fluid
Whistling sound = partial E.T. obstruction
No sound = complete obstruction of E.T.
36
37. – Complications:
• Injury to Eustachian tube opening
• Bleeding from nose
• Transmission of nasal & nasopharyngeal infection into
middle ear
• Rupture of atrophic area of tympanic membrane
37
38. • Toynbee’s test
– Uses negative pressure
– Ask the patient to swallow while nose is pinched
– Draws air from middle ear to nasopharynx – inward
movement of t.m.
38
39. • Tympanometry (inflation-deflation test)
– +Ve & -ve pressures are created in the external ear
and the patient swallows repeatedly
– in patients with perforated or intact tympanic
membrane
• Radiological Test
• Saccharine/ Methylene blue Test
– Saccharine solution
– Methylene blue dye
– Ear drops into ear with TM perforation
• Sonotubometry
39
41. Tubal Blockage
EROSION OF INCUDOSTAPEDIAL JOINT
RETRACTION POCKET/CHOLESTEATOMA
ATELECTATIC EAR/PERFORATION
OME(THIN WATERY OR MUCOID DISCHARGE)
TRANSUDATE IN ME/HAEMORRHAGE PROLONGED TUBAL BLOCKAGE/DYSFUNCTION
RETRACTION OF TM
-VE PRESSURE IN ME
ABSORPTION OF ME GASES
ACUTE TUBAL BLOCKAGE
41
43. • Symptoms of tubal occlusion
– Otalgia
– Hearing loss
– Popping sensation
– Tinnitus
– Disturbances of equilibrium
• Signs of tubal occlusion
– Retracted TM
– Congestion along the handle
of malleus and pars tensa
– Transudate behind TM
43
44. • Clinical causes of ET obstruction
– Upper respiratory tract infection
– Allergy
– Sinusitis
– Nasal polypi
– DNS
– Hypertrophic adenoids
– Nasopharyngeal tumour/ mass
– Cleft palate
– Submucous cleft palate
– Down’s syndrome
44
45. Adenoids
• Adenoids cause tubal dysfunction by:
– Mechanical obstruction of the tubal opening
– Acting as reservoir for pathogenic organisms
– Inflammatory mediators in allergy cause tubal
blockage
• Adenoids can cause otitis media with effusion or
recurrent acute otitis media
• Adenoidectomy
45
48. Cleft palate
• Tubal dysfunction due to:
– Abnormalities of torus tubaris
– Tensor veli palatini doe not insert into the torus
tubaris
• Otitis media with effusion is common in these
patients
48
50. Barotrauma
• Non suppurative condition resulting from failure
of E Tube to maintain M Ear pressure at ambient
atmospheric level
• Cause:
– Rapid descent during air flight
– Under water diving
– Compression in pressure chamber
• When atm pressure > M E pressure by critical
pressure of 90mm Hg E T gets locked – Negative
pressure in ME
• T M retraction - transudation/ h’ge
50
52. • Any obstruction in the ventilation pathway
retraction pockets or atelectasis of tympanic
membrane
– Obstruction of Eustachian tube total atelectasis of tm
– Obstruction at additus cholesterol granuloma &
collection of mucoid discharge in mastoid air cells
52
53. • Other changes
– Thin atrophic TM
– Cholesteatoma
– Ossicular necrosis
– Tympanosclerotic changes
• Management
– Repair of irreversible pathologic processes
– Establishment of ventilation
53
54. Patulous Eustachian Tube
• ET is abnormally patent
• Causes:
– Idiopathic, rapid weight loss, pregnancy (esp 3rd
trim) & multiple sclerosis
• Chief complaints
– Autophony, hearing his own breath sounds
• Pressure changes in the nasopharynx are easily
transmitted to the ME
• Movements of the TM can be seen with
inspiration & expiration
54
55. • Management
– Acute cases Usually self-limiting
– Weight gain & oral administration of KI
– Long standing cases = cauterisation/ insertion of grommet
55
56. EXAMINATION OF EUSTACHIAN TUBE
Pharyngeal end of eustachian tube :posterior
rhinoscopy, rigid nasal endoscope or flexible
nasopharyngoscope
Tympanic end :microscope or endoscope
Simple examination of TM may reveal retraction
pockets or fluid in the me
Movements of TM with respiration point to
patulous eustachian tube 56
57. • Aetiologic causes of eustachian tube
dysfunction assessed through:
– Nasal examination
– Endoscopy
– Tests of allergy
– CT scan of temporal bones
– MRI to exclude multiple sclerosis
57